COPD Exacerbation Follow Up

Investigating the Impact of AI Tools on COPD Follow-Up

Recruiting
40 years or above
All
Phase N/A
485 participants needed
2 Locations

Study Overview

The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.

Study Details

Time perspective: This study will collect data prospectively for the Experimental cohort and retrospectively for the Control cohort. There is also an Exploratory cohort which will collect retrospective and prospective data.

Eligibility Criteria

You may be eligible for this study if you meet the following criteria:

  • Conditions: COPD (Chronic Obstructive Pulmonary Disease)
  • Age: 40 years or above
  • Gender: All

Inclusion Criteria:

  • Patients aged 40 years or older at the time of arrival to the emergency department.
  • Patients with a clinical diagnosis of COPD who present to the emergency department for a moderate or severe COPD exacerbation.
  • A moderate exacerbation is defined as an acute exacerbation requiring either systemic corticosteroids (such as intramuscular, intravenous or oral) and/or antibiotics.
  • A severe exacerbation is defined as an acute exacerbation requiring hospitalization, or observation for >24 hours in emergency department/urgent care facility or resulting in death.
  • Patients on dual (LABA/LAMA, LABA/ICS, LAMA/ICS) or triple (LABA/LAMA/ICS) long-acting bronchodilator inhalers.

Exclusion Criteria:

  • Patients on bronchodilator inhaler monotherapy.
  • Patients leaving against medical advice or expiring during hospitalization.
  • Patients with tracheostomy.
  • Patients with advanced cancer.
  • Patients who have received a lung transplant.
  • Discharge to hospice care.
  • Transfer to another hospital.

This study investigates COPD exacerbation. It looks into how an AI-enabled clinical workflow tool might affect follow-up care by respiratory specialists.

The study focuses on evaluating the impact of this tool on clinical outcomes. It examines how the tool might help in managing care after an acute exacerbation.

  • Who can participate: Participants must be 40 years or older and have a clinical diagnosis of COPD. They should have visited the emergency department for a moderate or severe COPD exacerbation and be on dual or triple long-acting bronchodilator inhalers.
  • Study details: Participants will be involved in using a tool to manage their care. The study will look at outcomes after an acute exacerbation.
Updated on 24 Apr 2026. Study ID: NCT07118306

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
United States Only: Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language